WHO prequalifies new simplified oral vaccine for cholera
While similar in efficacy to existing vaccines, the inactivated oral vaccine has a simplified formulation, allowing opportunities to rapidly increase production capacity
Elekta and Merck & Co to create health monitor for RCC
Digital health monitoring firm Elekta has partnered with US pharmaceutical firm Merck & Co to develop patient monitoring for people with renal cell carcinoma (RCC)